Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1991 1
1992 1
1993 1
1994 3
2001 1
2003 1
2004 1
2005 2
2006 2
2007 1
2008 2
2009 1
2010 1
2011 3
2012 1
2013 3
2015 1
2016 2
2017 5
2018 3
2022 1
2023 1
2024 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

39 results

Results by year

Filters applied: . Clear all
Page 1
Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis.
Montalban X, Hauser SL, Kappos L, Arnold DL, Bar-Or A, Comi G, de Seze J, Giovannoni G, Hartung HP, Hemmer B, Lublin F, Rammohan KW, Selmaj K, Traboulsee A, Sauter A, Masterman D, Fontoura P, Belachew S, Garren H, Mairon N, Chin P, Wolinsky JS; ORATORIO Clinical Investigators. Montalban X, et al. N Engl J Med. 2017 Jan 19;376(3):209-220. doi: 10.1056/NEJMoa1606468. Epub 2016 Dec 21. N Engl J Med. 2017. PMID: 28002688 Free article. Clinical Trial.
Safety, tolerability, and efficacy of subcutaneous efgartigimod in patients with chronic inflammatory demyelinating polyradiculoneuropathy (ADHERE): a multicentre, randomised-withdrawal, double-blind, placebo-controlled, phase 2 trial.
Allen JA, Lin J, Basta I, Dysgaard T, Eggers C, Guptill JT, Gwathmey KG, Hewamadduma C, Hofman E, Hussain YM, Kuwabara S, Le Masson G, Leypoldt F, Chang T, Lipowska M, Lowe M, Lauria G, Querol L, Simu MA, Suresh N, Tse A, Ulrichts P, Van Hoorick B, Yamasaki R, Lewis RA, van Doorn PA; ADHERE Study Group. Allen JA, et al. Lancet Neurol. 2024 Oct;23(10):1013-1024. doi: 10.1016/S1474-4422(24)00309-0. Lancet Neurol. 2024. PMID: 39304241 Clinical Trial.
Clinical consequences of aspirin and clopidogrel resistance: an overview.
Mijajlovic MD, Shulga O, Bloch S, Covickovic-Sternic N, Aleksic V, Bornstein NM. Mijajlovic MD, et al. Among authors: shulga o. Acta Neurol Scand. 2013 Oct;128(4):213-9. doi: 10.1111/ane.12111. Epub 2013 Feb 21. Acta Neurol Scand. 2013. PMID: 23432706 Review.
Nanoporous Gold for Enzyme Immobilization.
Stine KJ, Jefferson K, Shulga OV. Stine KJ, et al. Among authors: shulga ov. Methods Mol Biol. 2017;1504:37-60. doi: 10.1007/978-1-4939-6499-4_5. Methods Mol Biol. 2017. PMID: 27770413
Genetic regulation of inflorescence development in chrysanthemum.
Shchennikova AV, Shulga OA, Angenent GC, Skryabin KG. Shchennikova AV, et al. Among authors: shulga oa. Dokl Biol Sci. 2003 Jul-Aug;391:368-70. doi: 10.1023/a:1025123222257. Dokl Biol Sci. 2003. PMID: 14556535 No abstract available.
CRISPR/Cas9-induced modification of the conservative promoter region of VRN-A1 alters the heading time of hexaploid bread wheat.
Miroshnichenko D, Timerbaev V, Klementyeva A, Pushin A, Sidorova T, Litvinov D, Nazarova L, Shulga O, Divashuk M, Karlov G, Salina E, Dolgov S. Miroshnichenko D, et al. Among authors: shulga o. Front Plant Sci. 2022 Dec 5;13:1048695. doi: 10.3389/fpls.2022.1048695. eCollection 2022. Front Plant Sci. 2022. PMID: 36544871 Free PMC article.
STICS: surface-tethered iterative carbohydrate synthesis.
Pornsuriyasak P, Ranade SC, Li A, Parlato MC, Sims CR, Shulga OV, Stine KJ, Demchenko AV. Pornsuriyasak P, et al. Among authors: shulga ov. Chem Commun (Camb). 2009 Apr 14;(14):1834-6. doi: 10.1039/b817684a. Epub 2009 Feb 18. Chem Commun (Camb). 2009. PMID: 19319417
39 results